Panagora Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,324
| Closed | -$126K | – | 3033 |
|
|
2021
Q1 | $126K | Buy |
25,324
+1,211
| +5% | +$6.03K | ﹤0.01% | 1876 |
|
|
2020
Q4 | $305K | Buy |
24,113
+4,751
| +25% | +$60.1K | ﹤0.01% | 1416 |
|
|
2020
Q3 | $190K | Sell |
19,362
-10,163
| -34% | -$99.7K | ﹤0.01% | 1533 |
|
|
2020
Q2 | $294K | Sell |
29,525
-27,039
| -48% | -$269K | ﹤0.01% | 1387 |
|
|
2020
Q1 | $500K | Sell |
56,564
-170,836
| -75% | -$1.51M | ﹤0.01% | 1124 |
|
|
2019
Q4 | $2.1M | Buy |
227,400
+27,191
| +14% | +$251K | 0.01% | 770 |
|
|
2019
Q3 | $1.18M | Sell |
200,209
-33,135
| -14% | -$195K | 0.01% | 953 |
|
|
2019
Q2 | $2.8M | Buy |
233,344
+101,152
| +77% | +$1.21M | 0.01% | 694 |
|
|
2019
Q1 | $1.6M | Buy |
132,192
+8,687
| +7% | +$105K | 0.01% | 925 |
|
|
2018
Q4 | $1.55M | Sell |
123,505
-29,313
| -19% | -$368K | 0.01% | 885 |
|
|
2018
Q3 | $2.27M | Sell |
152,818
-81,288
| -35% | -$1.21M | 0.01% | 790 |
|
|
2018
Q2 | $3.94M | Buy |
234,106
+114,905
| +96% | +$1.93M | 0.02% | 618 |
|
|
2018
Q1 | $2.73M | Buy |
119,201
+81,981
| +220% | +$1.88M | 0.01% | 756 |
|
|
2017
Q4 | $963K | Buy |
+37,220
| New | +$963K | ﹤0.01% | 1151 |
|
|
2015
Q4 | – | Sell |
-3,088
| Closed | -$58K | – | 2391 |
|
|
2015
Q3 | $58K | Sell |
3,088
-15,915
| -84% | -$299K | ﹤0.01% | 1958 |
|
|
2015
Q2 | $283K | Sell |
19,003
-13,655
| -42% | -$203K | ﹤0.01% | 1532 |
|
|
2015
Q1 | $495K | Buy |
+32,658
| New | +$495K | ﹤0.01% | 1318 |
|